Proposta del perfil de competències d'un professional de comunicació a l'administració pública

L’objecte d’aquest estudi és fer la proposta del perfil d’un professional de la comunicació a l’Administració Pública, dins l’àmbit de Barcelona, en funció d’una gestió per competències. A l’Administració Pública es dóna un buit important respecte al concepte de competències, així com en el marc acadèmic estan definides i classificades, en el món laboral, es troben a l’aire, encara no són una realitat, són competències latents. La nostra aportació, és la traducció de les funcions exigides en competències per tal d’intentar unificar el perfil d’un professional de la comunicació a l’Administració Pública.

Dispositius handheld per a aplicacions mèdiques: disseny i implementació d'interfícies del protocol Start

Els sistemes dʼatenció mèdica en situacions de pèrdues humanes massives necessiten classificar un número molt elevat de víctimes en un temps limitat i amb pocs recursos disponibles. Els mètodes clàssics es basen en una etiqueta de triatge de paper on el personal dʼemergències anota lʼestat del pacient juntament amb una quantitat reduïda dʼinformació. En aquest projecte descrivim lʼanàlisi, disseny i implementació dʼinterfícies gràfiques per dispositius mòbils pel protocol de triatge START, per ser utilitzades pels equips dʼemergència. Els components del projecte inclouen un dispositiu portàtil Nokia N810 amb connexió GPS, i IDBlue, un lector dʼetiquetes RFID per Bluetooth.

Empleabilidad y Adaptabilidad de los jóvenes con inteligencia límite y sus procesos de integración laboral: Hacia un modelo de formación y de orientación para su inserción en el mundo del trabajo

ii. Aquest estudi planteja un model de formació i d'orientació per la millora de l’empleabilitat i l’adaptabilitat d’un grup especialment vulnerable, els joves amb intel•ligència límit, a partir d’un procés de detecció de necessitats de les competències bàsiques i laborals exigides pel mercat de treball. El model sorgeix de l’estudi dels programes i actuacions de formació i d’orientació que els serveis locals d’ocupació i/o d'integració laboral dissenyen i desenvolupen per la inserció laboral dels joves amb intel•ligència límit en el mercat de treball obert i competitiu.

Comparable Survival Between HIV+ and HIV- non-Hodgkin and Hodgkin Lymphoma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation.

Autologous stem cell transplantation (ASCT) has been successfully used in HIV-related lymphoma (HIV-Ly) patients on highly active antiretroviral therapy. We report the first comparative analysis between HIV-Ly and a matched cohort of HIV(-) lymphoma patients. This retrospective European Group for Blood and Marrow Transplantation study included 53 patients (66% non-Hodgkin and 34% Hodgkin lymphoma) within each cohort. Both groups were comparable except for the higher proportion of males, mixed-cellularity Hodgkin lymphoma and patients receiving granulocyte colony-stimulating factor before engraftment and a smaller proportion receiving total body irradiation-based conditioning within the HIV-Ly cohort. Incidence of relapse, overall survival, and progression-free survival were similar in both cohorts. A higher nonrelapse mortality within the first year after ASCT was observed in the HIV-Ly group (8% vs 2%), predominantly because of early bacterial infections, although this was not statistically significant and did not influence survival. Thus, within the highly active antiretroviral therapy era, HIV patients should be considered for ASCT according to the same criteria adopted for HIV(-) lymphoma patients.

Electrocardiographic findings in Mexican chagasic subjects living in high and low endemic regions of Trypanosoma cruzi infection

In México the first human chronic chagasic case was recognized in 1940. In spite of an increasing number of cases detected since that time, Chagas disease in México has been poorly documented. In the present work we studied 617 volunteers subjects living in high and low endemic regions of Trypanosoma cruzi infection with seroprevalence of 22% and 4% respectively. Hemoculture performed in those seropositive subjects failed to demonstrate circulating parasites, however polymerase chain reaction identified up to 60% of them as positives. A higher level of anti-T. cruzi antibodies was observed in seropositive residents in high endemic region, in spite of similar parasite persistence (p < 0.05). On standard 12 leads electrocardiogram (ECG) 20% to 22% seropositive individuals from either region showed right bundle branch block or ventricular extrasystoles which were more prevalent in seropositive than in seronegative individuals (p < 0.05). In conclusion, the frequency or type of ECG abnormality was influenced by serologic status but not by endemicity or parasite persistence. Furthermore, Mexican indeterminate patients have a similar ECG pattern to those reported in South America.

Creació d'un entorn web de treball per a una biblioteca : Fent ús de Struts, Tiles i Hibernate

El següent projecte final de carrera vol assolir assolir la creació d'un entorn web de treball per a una Biblioteca. L'aplicació al món real es base en un mòdul administratiu, que podrà ser utilitzat pels treballadors de la pròpia Biblioteca i un mòdul que servirà de consulta als socis.

Enfermedad pulmonar obstructiva crónica: proceso asistencial integrado. 2ª ed

En noviembre de 2015, se ha publicado la 3ª edición de este proceso (http://hdl.handle.net/10668/2125). Existe una guía de información para pacientes "Conozca cómo vivir mejor con la EPOC" basada en la 2ª edición de este Proceso.

Leiomiosarcoma de vesícula seminal. Presentación de un caso

Aims: Leiomyosarcoma of the seminal vesicle is extremely rare and very little information is available on how best it should be treated. The advantage of adjuvant therapy treatment is unclear. Methods and results: We report a case of leiomyosarcoma arising from the seminal vesicle in a 65-year-old man. Conclusion: Leiomyosarcoma is a malignant neoplasm with a poor prognosis and radical surgical excision is the treatment of choice.

Carcinoma verrugoso de vagina. Presentacion de un caso

Verrucous carcinoma of the vagina is a rare neoplasm. This entity is a slow-growing, locally invasive but generally nonmetastasizing neoplasm, with a characteristic gross and microscopic appearance. We report a case of verrucous carcinoma of the vagina in a postmenopausal woman diagnosed 4 years after transvaginal hysterectomy for grade 4 uterine prolapse. We also discuss the differential diagnosis and treatment.Verrucous carcinoma of the vagina is a rare neoplasm. The differential diagnosis includes typical squamous cell carcinoma, warty carcinoma, and condyloma acuminatum. Surgery remains the most effective treatment.

Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing

BACKGROUND: Epidermal growth factor receptor (EGFR) and its downstream factors KRAS and BRAF are mutated in several types of cancer, affecting the clinical response to EGFR inhibitors. Mutations in the EGFR kinase domain predict sensitivity to the tyrosine kinase inhibitors gefitinib and erlotinib in lung adenocarcinoma, while activating point mutations in KRAS and BRAF confer resistance to the anti-EGFR monoclonal antibody cetuximab in colorectal cancer. The development of new generation methods for systematic mutation screening of these genes will allow more appropriate therapeutic choices. METHODS: We describe a high resolution melting (HRM) assay for mutation detection in EGFR exons 19-21, KRAS codon 12/13 and BRAF V600 using formalin-fixed paraffin-embedded samples. Somatic variation of KRAS exon 2 was also analysed by massively parallel pyrosequencing of amplicons with the GS Junior 454 platform. RESULTS: We tested 120 routine diagnostic specimens from patients with colorectal or lung cancer. Mutations in KRAS, BRAF and EGFR were observed in 41.9%, 13.0% and 11.1% of the overall samples, respectively, being mutually exclusive. For KRAS, six types of substitutions were detected (17 G12D, 9 G13D, 7 G12C, 2 G12A, 2 G12V, 2 G12S), while V600E accounted for all the BRAF activating mutations. Regarding EGFR, two cases showed exon 19 deletions (delE746-A750 and delE746-T751insA) and another two substitutions in exon 21 (one showed L858R with the resistance mutation T590M in exon 20, and the other had P848L mutation). Consistent with earlier reports, our results show that KRAS and BRAF mutation frequencies in colorectal cancer were 44.3% and 13.0%, respectively, while EGFR mutations were detected in 11.1% of the lung cancer specimens. Ultra-deep amplicon pyrosequencing successfully validated the HRM results and allowed detection and quantitation of KRAS somatic mutations. CONCLUSIONS: HRM is a rapid and sensitive method for moderate-throughput cost-effective screening of oncogene mutations in clinical samples. Rather than Sanger sequence validation, next-generation sequencing technology results in more accurate quantitative results in somatic variation and can be achieved at a higher throughput scale.

Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection.

The recognition of pathogen-derived structures by C-type lectins and the chemotactic activity mediated by the CCL2/CCR2 axis are critical steps in determining the host immune response to fungi. The present study was designed to investigate whether the presence of single nucleotide polymorphisms (SNPs) within DC-SIGN, Dectin-1, Dectin-2, CCL2 and CCR2 genes influence the risk of developing Invasive Pulmonary Aspergillosis (IPA). Twenty-seven SNPs were selected using a hybrid functional/tagging approach and genotyped in 182 haematological patients, fifty-seven of them diagnosed with proven or probable IPA according to the 2008 EORTC/MSG criteria. Association analysis revealed that carriers of the Dectin-1(rs3901533 T/T) and Dectin-1(rs7309123 G/G) genotypes and DC-SIGN(rs4804800 G), DC-SIGN(rs11465384 T), DC-SIGN(7248637 A) and DC-SIGN(7252229 C) alleles had a significantly increased risk of IPA infection (OR = 5.59 95%CI 1.37-22.77; OR = 4.91 95%CI 1.52-15.89; OR = 2.75 95%CI 1.27-5.95; OR = 2.70 95%CI 1.24-5.90; OR = 2.39 95%CI 1.09-5.22 and OR = 2.05 95%CI 1.00-4.22, respectively). There was also a significantly increased frequency of galactomannan positivity among patients carrying the Dectin-1(rs3901533_T) allele and Dectin-1(rs7309123_G/G) genotype. In addition, healthy individuals with this latter genotype showed a significantly decreased level of Dectin-1 mRNA expression compared to C-allele carriers, suggesting a role of the Dectin-1(rs7309123) polymorphism in determining the levels of Dectin-1 and, consequently, the level of susceptibility to IPA infection. SNP-SNP interaction (epistasis) analysis revealed significant interactions models including SNPs in Dectin-1, Dectin-2, CCL2 and CCR2 genes, with synergistic genetic effects. Although these results need to be further validated in larger cohorts, they suggest that Dectin-1, DC-SIGN, Dectin-2, CCL2 and CCR2 genetic variants influence the risk of IPA infection and might be useful in developing a risk-adapted prophylaxis.

Proceso de alertas. 2ª ed.

En la port.: Secretaría General de Salud Pública, Inclusión Social y Calidad de vida. 2ª EDICIÓN (2013), revisada por Luis Manuel Santiago Fernández, María José Viñuela González, Juan Antonio Ortiz Batanero, Carmen Añón García, Carmen Pacheco Rodríguez, María Zambrano Lozano, Juan Francisco Pereira Muñoz, José Luis Márquez Díaz, Ángel Mario Martín, Belén Ramos Fernández e Inmaculada Cuesta Bertomeu.

Proceso de alertas. 2ª ed.

En la port.: Secretaría General de Salud Pública, Inclusión Social y Calidad de vida. 2ª EDICIÓN (2013), revisada por Luis Manuel Santiago Fernández, María José Viñuela González, Juan Antonio Ortiz Batanero, Carmen Añón García, Carmen Pacheco Rodríguez, María Zambrano Lozano, Juan Francisco Pereira Muñoz, José Luis Márquez Díaz, Ángel Mario Martín, Belén Ramos Fernández e Inmaculada Cuesta Bertomeu.

Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).

There is strong evidence suggesting the presence of a genetic component in the aetiology of multiple myeloma (MM). However no genetic risk factors have been unequivocally established so far. To further our understanding of the genetic determinants of MM risk, a promising strategy is to collect a large set of patients in a consortium, as successfully done for other cancers. In this article, we review the main findings in the genetic susceptibility and pharmacogenetics of MM and present the strategy of the IMMEnSE (International Multiple Myeloma rESEarch) consortium in contributing to determine the role of genetic variation in pharmacogenetics and in MM risk.